메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
구민희 (동남권원자력의학원 약제실) 제남경 (부산대학교)
저널정보
한국병원약사회 병원약사회지 병원약사회지 제38권 제2호
발행연도
2021.1
수록면
171 - 184 (14page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Background : In July 2017, breast cancer surgery codes have been revised to more accurately describe a procedure of breast cancer surgery. This study aimed to investigate the current practice patterns of breast cancer surgery and the subsequent adjuvant chemotherapy after the revision of breast cancer surgery codes. Methods : We analyzed the 2018 inpatient datasets provided by the Health Insurance Review and Assessment Service (HIRA-NIS-2018-0047). Female patients with non-metastatic breast cancer who underwent breast cancer surgery and adjuvant chemotherapy were selected. Multinomial logistic regression analysis was performed to explore the relationships among variables regarding the selection of adjuvant chemotherapy relative to the doxorubicin and cyclophosphamide (AC) regimen. Results : Breast-conserving surgery was performed more frequently than mastectomy (70.2% vs. 29.8%) in 2018. For study subjects who underwent axillary lymph node dissection, the odds ratio for selecting sequential anthracycline-cyclophosphamide and taxane (AC-T) as adjuvant chemotherapy over AC was 23.27 (95% confidence interval [CI]=8.61-62.91). For patients aged 65 years or older, the odds ratio for selecting cyclophosphamide, methotrexate, and 5-Fluorouracil (CMF) as adjuvant chemotherapy over AC was 12.16 (95% CI=3.22-46.00). Conclusion : Factors influencing the choice of adjuvant chemotherapy were associated with age and presence of positive lymph nodes.

목차

등록된 정보가 없습니다.

참고문헌 (31)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0